[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346160-105":59,"doc-detail-346160-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","human-y-chromosome-pan-organ-mapping-reveals-progressive-mosaic-loss-from-normal-to-cancer","Human Y chromosome pan-organ mapping reveals progressive mosaic loss from normal to cancer","","Human Y chromosome pan-organ mapping reveals progressive mosaic loss from normal to cancer, examining loss of the Y chromosome (LOY) as a frequent male-tumor event. Using a FISH-based pan-organ assay targeting X- and Y-chromosome centromeres, the study quantifies mosaic LOY (mLOY) across 1,000 male tissue samples from 405 individuals spanning 11 organs. A YchrFISH mLOY score is validated against transcriptomic Y-chromosome dosage proxies. Results show tumor-type variation, higher mLOY in malignant than adjacent normal tissues, and spatial transcriptional gradients supporting field cancerization.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/human-y-chromosome-pan-organ-mapping-reveals-progressive-mosaic-loss-from-normal-to-cancer/346160/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/human-y-chromosome-pan-organ-mapping-reveals-progressive-mosaic-loss-from-normal-to-cancer/346160.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is being measured in this study?","Question",{"text":112,"@type":113},"The study measures mosaic loss of the Y chromosome (mLOY) across many male tissues using a FISH-based assay targeting X- and Y-chromosome centromeres.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is the mLOY score generated and validated?",{"text":117,"@type":113},"Automated image processing produces a quantitative FISH-based mLOY score (YchrFISH), which is validated against an RNA-seq transcriptomic surrogate of Y-chromosome dosage.",{"name":119,"@type":110,"acceptedAnswer":120},"What patterns of mLOY are observed across normal and cancer tissues?",{"text":121,"@type":113},"mLOY burden varies by tumor type and declines progressively from cancer-free normal tissues to histologically normal tissues adjacent to cancer, with consistently greater mLOY in malignant compared with tumor-adjacent tissue.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346160,1790683820,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","RESE AR CH  \nARTICLE  \nAuthorship note: AG and HY contributed equally to this work.  \nCopyright: © 2026, Gertych et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.  \nSubmitted: November 5, 2025  \nAccepted: July 14, 2026  \nPublished: September 8, 2026  \nReference information: JCI Insight. 2026;11(17):e201996 .  \n[https://doi.org/10.1172/jci](https://doi.org/10.1172/jci). insight.201996 .  \nHuman Y chromosome pan-organ mapping reveals progressive mosaic loss from normal to cancer  \nArkadiusz Gertych,1,2 Huihui Ye,2 Xingyu Chen,3,4 Eric Vail,2 V. Krishnan Ramanujan,2 Lauren Brady,5 Lawrence D. True,6 Peter S. Nelson,5,6 Peter R. Carroll,7 and Dan Theodorescu2,3,8  \n1Department of Surgery, 2Department of Pathology and Laboratory Medicine, 3Department of Urology, and 4Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA. 5Fred Hutchinson Cancer Center, Seattle, Washington, USA. 6Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA. 7Department of Urology, UCSF, San Francisco, California, USA. 8University of Arizona Comprehensive Cancer Center, Tucson, Arizona, USA.  \nBACKGROUND. Loss of theY chromosome (LOY) is a frequent event in male tumors and has been linked to cancer progression. However, the degree of mosaic LOY (mLOY) within normal tissues from men with or without cancer remains uncharacterized.  \nMETHODS. Here we used a FISH-based assay targeting X-andY-chromosome centromeres to perform a pan-organ analysis of mLOY in 1,000 male tissue samples from 405 individuals representing 11 organs. Automated image processing generated a quantitative FISH-based mLOY score (YchrFISH) that we validated against a transcriptomic surrogate of Y-chromosome dosage from RNA-seq data.  \nRESULTS. mLOY burden varied by tumor type, with highest degree in colorectal carcinoma. Across tissue groups, YchrFISH scores declined progressively from normal tissues of cancer-free men to histologically normal tissues adjacent to cancer and carcinoma (P \u003C 0.0001) . Paired analyses confirmed consistently greater mLOY in malignant compared with tumor-adjacent histologically normal tissue in different organs. Spatially resolved RNA-seq maps of bladders removed for cancer demonstrated a transcriptional gradient of Y-chromosome loss from normal urothelium through intraepithelial neoplasia to invasive carcinoma.  \nCONCLUSION. mLOY gradients exist across histologically normal and malignant tissues, consistent with the concept of field cancerization. Our findings support epithelial mLOY as a biomarker of early malignant transformation and, to our knowledge, a previously unrecognized hallmark of male oncogenesis.  \nFUNDING. NIH grants R35CA294022, P01CA163227, and P50CA97186 (the Pacific Northwest Prostate Cancer SPORE) and the Institute for Prostate Cancer Research.  \nIntroduction  \nLoss of the Y chromosome (LOY) in a certain proportion of peripheral blood mononuclear cells (PBMCs)  \n(1), termed mosaic LOY (mLOY) (2), is the most common genomic alteration in aging males and is linked to increased incidence and mortality in several cancer types, including lung, prostate, colon, and bladder (3–7) . mLOY has also been observed in cancer cells and its degree varies in different tumor types, with the highest seen in papillary renal cell carcinoma (80%) and esophageal cancer (57%) and the lowest (\u003C2%) seen in pheochromocytoma, paraganglioma, and thymoma (8, 9) . While mLOY was extensively studied in blood cells and tumor tissue in pan-cancer genomic analyses, the degree of mLOY in normal tissue and premalignant lesions has not been systematically studied across different types of tissue.  \nSeveral studies have been performed to evaluate the degree of mLOY in benign tissues in various organs. A study of 277 samples of histologically normal urothelium and 145 bladder urothelial carcinoma showed that mLOY identified","cbCaiicUnvmcbMmz","https://ap.wps.com/l/cbCaiicUnvmcbMmz","pdf",7645586,12,"English","# Background\n# Methods\n# Results\n## Multiorgan tissue mapping and scoring\n## Spatial RNA-seq gradients\n# Conclusion","[{\"question\":\"What is being measured in this study?\",\"answer\":\"The study measures mosaic loss of the Y chromosome (mLOY) across many male tissues using a FISH-based assay targeting X- and Y-chromosome centromeres.\"},{\"question\":\"How is the mLOY score generated and validated?\",\"answer\":\"Automated image processing produces a quantitative FISH-based mLOY score (YchrFISH), which is validated against an RNA-seq transcriptomic surrogate of Y-chromosome dosage.\"},{\"question\":\"What patterns of mLOY are observed across normal and cancer tissues?\",\"answer\":\"mLOY burden varies by tumor type and declines progressively from cancer-free normal tissues to histologically normal tissues adjacent to cancer, with consistently greater mLOY in malignant compared with tumor-adjacent tissue.\"}]","Human Y chromosome pan-organ mapping reveals progressive mosaic loss from normal to cancer | PDF",1790060318,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/365260ea99c61ad107b6506376efdff5.webp",983,1315,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/54cc7bba1ef6f38679d8fdaf8efc3d8e.webp",982,1314,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d4c50a3e4c4a882213a954405876e14.webp",981,1312,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72b954cce4ecd5fa653392beb7ba71a1.webp",980,1311]